Neoplastic transformation results in a wide variety of cellular alterations that impact the
growth, survival, and general behavior of affected tissue. Although genetic alterations …

Hepatocellular carcinoma (HCC) is ranked as the 5 th common type of cancer worldwide
and is considered as the 3 rd common reason for cancer-related deaths. HCC often occurs …

The focus of this article is to review the recent advances in proteome analysis of human
body fluids, including plasma/serum, urine, cerebrospinal fluid, saliva, bronchoalveolar …

Cancer is the second most common cause of death in developed countries with
approximately 14 million newly diagnosed individuals and over 6 million cancer‐related …

Hepatocellular carcinoma is the 5th most common cancer in the world. Prognosis for this
disease is poor since hepatocellular carcinoma is mostly diagnosed at an advanced stage …

Background While the underlying causes of cancer are genetic modifications, changes in
cellular states mediate cancer development. Tumor cells display markedly changed …

The glycosylation pattern of alpha fetoprotein (AFP) paves the basis for precise early
diagnosis of hepatocellular carcinoma (HCC). However, existing analytical methods ignore …

The application of mass spectrometry to identify disease biomarkers in clinical fluids like
serum using high throughput protein expression profiling continues to evolve as technology …

Serological markers for hepatocellular carcinoma (HCC) are important for early diagnosis,
as well as monitoring of tumour aggressiveness, treatment responsiveness, recurrence and …

Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of
hepatitis B or C virus infection. Research in recent years has uncovered important molecular …